Showing posts with the label coursesShow all
October 27, 2021
Philippines to receive 300,000 courses of Merck's COVID-19 pill
An experimental COVID-19 therapy tablet, referred to as molnupiravir and being developed by Merck & Co Inc and Rid…
Read more